Stryker Corporation(NYSE:SYK) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Jul 21, 2016. Company reported revenue of $2.84B. Analysts estimated a revenue of $2.79B. Earnings per share were $1.39. Analysts had estimated an EPS of $1.37.
In a different note, Guggenheim Securities said it Initiates Coverage on Stryker Corporation, according to a research note issued on Jun 9, 2016. The shares have been rated ‘Buy’ by the firm. On Apr 27, 2016, Sterne Agee CRT said it Upgrades its rating on Stryker Corporation. The shares have been rated ‘Buy’ by the firm. On Apr 27, 2016, Argus Research said it Maintains its rating on Stryker Corporation. In the research note, the firm Raises the price-target to $120.00 per share. The shares have been rated ‘Buy’ by the firm.
Stryker Corporation (SYK) made into the market gainers list on Wednesdays trading session with the shares advancing 0.49% or 0.6 points. Due to strong positive momentum, the stock ended at $122.36, which is also near the day’s high of $122.65. The stock began the session at $122.3 and the volume stood at 12,97,449 shares. The 52-week high of the shares is $123.55 and the 52 week low is $86.68. The company has a current market capitalization of $45,760 M and it has 37,39,81,100 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jul 19, 2016, Ronda E Stryker (director) sold 12,000 shares at $122.11 per share price.Also, On Jul 7, 2016, Katherine Ann Owen (VP, Strategy and IR) sold 6,674 shares at $121.21 per share price.On Jun 8, 2016, Srikant Datar (director) sold 6,565 shares at $113.90 per share price, according to the Form-4 filing with the securities and exchange commission.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.